MDxHealth SA (MDXH) Invested Capital (2020 - 2024)

MDxHealth's Invested Capital history spans 5 years, with the latest figure at $150.8 million for Q4 2024.

  • For Q4 2024, Invested Capital rose 22.14% year-over-year to $150.8 million; the TTM value through Dec 2024 reached $150.8 million, up 22.14%, while the annual FY2024 figure was $150.8 million, 22.14% up from the prior year.
  • Invested Capital for Q4 2024 was $150.8 million at MDxHealth, up from $123.4 million in the prior quarter.
  • Across five years, Invested Capital topped out at $150.8 million in Q4 2024 and bottomed at $28.6 million in Q4 2020.
  • The 5-year median for Invested Capital is $115.2 million (2022), against an average of $98.1 million.
  • The largest annual shift saw Invested Capital surged 152.58% in 2021 before it rose 7.2% in 2023.
  • A 5-year view of Invested Capital shows it stood at $28.6 million in 2020, then skyrocketed by 152.58% to $72.3 million in 2021, then soared by 59.19% to $115.2 million in 2022, then grew by 7.2% to $123.4 million in 2023, then rose by 22.14% to $150.8 million in 2024.
  • Per Business Quant, the three most recent readings for MDXH's Invested Capital are $150.8 million (Q4 2024), $123.4 million (Q4 2023), and $115.2 million (Q4 2022).